USPTO 2015–2025 USPTO PatentsView Foreign Corporation

THE Walter AND Eliza HALL Institute OF Medical Research

USPTO PatentsView assignee record - 37 granted patents across 19 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS).

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Explore the portfolio See the ranking

Total patents granted

CPC technology areas

15.5

Avg claims per patent

+6%

5-year filing velocity

The verdict

THE holds 37 US patents across 19 technology areas, rank #8,691 of 50,000 tracked assignees.

#8,691
of 50,000 US assignees by volume: Top 30%
by Innovation Score (42.7/100): 15.5
avg claims per patent: +6%
filing velocity, last 5 yrs

Portfolio overview

THE Walter AND Eliza HALL Institute OF Medical Research has been granted 37 US utility patents between 2015 and 2025, placing THE Walter AND Eliza HALL Institute OF Medical Research at rank #8,691 across all assignees tracked by PlainPatent. This portfolio spans 19 distinct Cooperative Patent Classification (CPC) subclasses, averaging 15.5 claims per patent with primary concentration in A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS). As a Foreign Corporation, THE Walter AND Eliza HALL Institute OF Medical Research is one of the more focused assignees in the PatentsView dataset. By volume, THE sits between Taizhou SUKK Furniture Co., Ltd (37 patents, rank #8,687) and TRIS Pharma Inc (37 patents, rank #8,695) - the closest US assignees by grant volume. The composite Innovation Score of 42.7/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 19 grants, compared with 18 in the 2015–2019 window, a +6% shift in five-year velocity. Steady filing volume suggests sustained innovation without dramatic pivots. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. THE Walter AND Eliza HALL Institute OF Medical Research's 15.5 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 19 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark THE Walter AND Eliza HALL Institute OF Medical Research against peers pursuing similar technology classes.

Taizhou SUKK Furn…

37
Tempur World

37
TGW Logistics

37
THE 13TH Research…

37
Tokai Kogyo

37
Tokyo ROPE MFG

37
Tornier SAS

37
TRIS Pharma

37
THE Walter AND El… ◀

37

What this shows THE holds 37 patents at rank #8,691, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near THE

By rank, the assignees closest to #8,691 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in THE's primary technology class.

THE's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

43 Top 30% higher than 70% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

THE Walter AND Eliza HALL Institute OF Medical Research patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	8	21.6%
2017	2	5.4%
2018	3	8.1%
2019	5	13.5%
2020	1	2.7%
2021	5	13.5%
2022	5	13.5%
2023	3	8.1%
2024	1	2.7%
2025	4	10.8%

Which technologies does THE Walter AND Eliza HALL Institute OF Medical Research patent most?

A61P - SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 32

A61K - PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES 31

C07K - PEPTIDES 22

Y02A - TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE 18

G01N - INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 17

C12N - MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA 16

C07D - HETEROCYCLIC COMPOUNDS 9

C12Q - MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS ; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES 5

C12G - WINE; PREPARATION THEREOF; ALCOHOLIC BEVERAGES ; PREPARATION OF ALCOHOLIC BEVERAGES NOT PROVIDED FOR IN SUBCLASSES C12C OR C12H 3

A01H - NEW PLANTS OR ; NON-TRANSGENIC; PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES 3

C12H - PASTEURISATION, STERILISATION, PRESERVATION, PURIFICATION, CLARIFICATION OR AGEING OF ALCOHOLIC BEVERAGES; METHODS FOR ALTERING THE ALCOHOL CONTENT OF FERMENTED SOLUTIONS OR ALCOHOLIC BEVERAGES 3

A23L - FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF 3

A23V - INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION 3

Y02P - CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS 3

C12C - BEER; PREPARATION OF BEER BY FERMENTATION ; PREPARATION OF MALT FOR MAKING BEER; PREPARATION OF HOPS FOR MAKING BEER 3

Top 15 of 19 technology areas

Patent Moat Analysis

Portfolio Volume Light

Tech Breadth Focused

Claim Depth Standard

Velocity Growing

Where it ranks

Overall rank by patents

#8,691

Across all tracked assignees

Innovation Score

42.7 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does THE Walter AND Eliza HALL Institute OF Medical Research hold?

THE Walter AND Eliza HALL Institute OF Medical Research holds 37 US granted patents filed between 2015 and 2025, spanning 19 technology areas.

What is THE Walter AND Eliza HALL Institute OF Medical Research's Innovation Score?

THE Walter AND Eliza HALL Institute OF Medical Research has an Innovation Score of 42.7 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does THE Walter AND Eliza HALL Institute OF Medical Research focus on?

THE Walter AND Eliza HALL Institute OF Medical Research's top technology area is A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS) with 32 patents. The company has filed patents in 19 CPC subclasses total.

Is THE Walter AND Eliza HALL Institute OF Medical Research's patent filing rate increasing or decreasing?

THE Walter AND Eliza HALL Institute OF Medical Research's recent filing velocity is +6% compared to the prior five-year period. The company is maintaining or growing its patent output.

What does claim depth mean for THE Walter AND Eliza HALL Institute OF Medical Research's patents?

THE Walter AND Eliza HALL Institute OF Medical Research's patents average 15.5 claims each. This falls within the standard range, providing solid legal coverage.

How is the THE Walter AND Eliza HALL Institute OF Medical Research patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

THE's 37 grants land it in the top 30% by Innovation Score, but volume alone doesn't tell you where the strength sits.

Read that count against the largest US assignees before treating it as dominance - THE ranks #8,691 of 50,000. Top 50 holders
Most of this portfolio concentrates in A61P - see who else leads that technology area. A61P leaders
Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.